You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


NICE recommends gene silencing therapy for porphyria patients on NHS

NICE have recommended the use of givosiran, a gene silencing therapy, on the NHS in England, as an option for the treatment of acute haptic porphyria (AHP), a painful disease usually first seen in young women in their 20s.